Skip to content

CBD: all studies

Page 22 of 38: studies 211 to 220 of 375, newest first. Back to the CBD overview

Research

Placebo Effects of Edible Cannabis: Reported Intoxication Effects at a 30-Minute Delay

Journal of Psychoactive Drugs August 3, 2017 Mallory Loflin, Mitch Earleywine, Stacey Farmer et al. 7 citations

Previous research has demonstrated the ability of non-active smoked cannabis cigarettes to induce subjective effects of intoxication (i.e., placebo effect). No studies have been conduced to test whether edible forms of cannabis, which are associated with a significant delay in onset of effect, are able to induce a placebo effect. In the present study, 20 participants were told that they would...

Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research

Frontiers in Pharmacology June 21, 2017 Rafael Naime Ruggiero, Matheus Teixeira Rossignoli, Jana Batista de Ross et al. 37 citations

Much of our knowledge of the endocannabinoid system in schizophrenia comes from behavioral measures in rodents, like prepulse inhibition of the acoustic startle and open-field locomotion, which are commonly used along with neurochemical approaches or drug challenge designs. Such methods continue to map fundamental mechanisms of sensorimotor gating, hyperlocomotion, social interaction, and...

DOI: 10.3389/fphar.2017.00399 (opens in new tab) Cannabidiol Cannabis Schizophrenia object-oriented programming Prepulse inhibition +7

Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis ‘amotivational’ hypotheses

Psychopharmacology September 2, 2016 Will Lawn, Tom P. Freeman, Rebecca Pope et al. 177 citations

RATIONALE: Anecdotally, both acute and chronic cannabis use have been associated with apathy, amotivation, and other reward processing deficits. To date, empirical support for these effects is limited, and no previous studies have assessed both acute effects of Δ-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), as well as associations with cannabis dependence. OBJECTIVES: The objectives of...

Telling true from false: cannabis users show increased susceptibility to false memories

Molecular Psychiatry March 31, 2015 Jordi Riba, Marta Valle, Frederic Sampedro et al. 41 citations

Previous studies on the neurocognitive impact of cannabis use have found working and declarative memory deficits that tend to normalize with abstinence. An unexplored aspect of cognitive function in chronic cannabis users is the ability to distinguish between veridical and illusory memories, a crucial aspect of reality monitoring that relies on adequate memory function and cognitive control....

Just say 'know': how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?

Addiction October 2014 Tom P. Freeman, Celia J. A. Morgan, Chandni Hindocha et al.

(1) To determine whether measured concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in individuals' own cannabis predict their estimates of drug potency and actual titration; and (2) to ascertain if these effects are influenced by frequency of use and cannabis type. Cross-sectional, naturalistic. Participants' own homes. A total of 247 cannabis users in the United...

Effects of Cannabis on Impulsivity: A Systematic Review of Neuroimaging Findings

Current Pharmaceutical Design May 10, 2014 Johannes Wrege, André Schmidt, Anna Walter et al. 96 citations

We conducted a systematic review to assess the evidence for specific effects of cannabis on impulsivity, disinhibition and motor control. The review had a specific focus on neuroimaging findings associated with acute and chronic use of the drug and covers literature published up until May 2012. Seventeen studies were identified, of which 13 met the inclusion criteria; three studies investigated...

DOI: 10.2174/13816128113199990428 (opens in new tab) Cannabidiol Impulsivity Neuroimaging Disinhibition +2

Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain

Frontiers in Pharmacology 2014 Raquel Levin, Fernanda Fiel Peres, Valéria de Almeida et al. 73 citations

Clinical and neurobiological findings suggest that the cannabinoids and the endocannabinoid system may be implicated in the pathophysiology and treatment of schizophrenia. We described that the spontaneously hypertensive rats (SHR) strain presents a schizophrenia behavioral phenotype that is specifically attenuated by antipsychotic drugs, and potentiated by proschizophrenia manipulations. Based...

Single doses of THC and cocaine decrease proficiency of impulse control in heavy cannabis users

British Journal of Pharmacology October 11, 2013 Janelle H. P. van Wel, Kim P. C. Kuypers, Eef L. Theunissen et al. 38 citations

BACKGROUND AND PURPOSE: Cannabis is the most popular drug used in the European Union, closely followed by cocaine. Whereas cannabis impairs neurocognitive function in occasional cannabis users, such impairments appear less prominent in heavy users, possibly as a result of tolerance. The present study was designed to assess whether the impairing effects of Δ(9) -tetrahydrocannabinol (THC) in...

DOI: 10.1111/bph.12425 (opens in new tab) Cannabidiol Impulsivity Psychomotor learning Neurocognitive +8

The effect of cannabis use on memory function: an update.

Substance Abuse and Rehabilitation 2013 Tabea Schoeler, Sagnik Bhattacharyya

Investigating the effects of cannabis use on memory function appears challenging. While early observational investigations aimed to elucidate the longer-term effects of cannabis use on memory function in humans, findings remained equivocal and pointed to a pattern of interacting factors impacting on the relationship between cannabis use and memory function, rather than a simple direct effect of...

Neurophysiological functioning of occasional and heavy cannabis users during THC intoxication

Psychopharmacology October 5, 2011 Eef L. Theunissen, Gerold F. Kauert, Stefan W. Toennes et al. 82 citations

RATIONALE: Experienced cannabis users demonstrate tolerance to some of the impairing acute effects of cannabis. OBJECTIVES: The present study investigates whether event-related potentials (ERPs) differ between occasional and heavy cannabis users after acute Δ9-tetrahydrocannabinol (THC) administration, as a result of tolerance. METHODS: Twelve occasional and 12 heavy cannabis users participated...

DOI: 10.1007/s00213-011-2479-x (opens in new tab) Full text (opens in new tab) Cannabidiol Delta-9-tetrahydrocannabinol Dronabinol Crossover study +6